POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

South Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills

Christian Fernsby |
South Korea authorised the use of Novavax Inc's vaccine on Wednesday and preparing to distribute the first of Pfizer's antiviral pills.

Article continues below



Topics: SOUTH KOREA     NOVAVAX    PFIZER   

At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said.

The pills, which were authorised for emergency use in December, will begin being used in treatments for more than 1,000 people per day starting on Friday, the ministry added

"By priority, oral treatment is planned to begin first for patients aged 65 or older, or patients with reduced immunity at home and residential treatment centres," a ministry spokesperson told a briefing.

South Korea's food and drug safety ministry, meanwhile, announced it had authorised the Novavax vaccine, which joins the ranks of previously authorised vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer, and Johnson & Johnson's Janssen.

South Korean vaccine developer SK Bioscience Co Ltd said it will produce the Novavax vaccine.


What to read next

Novavax seeks WHO approval for COVID-19 vaccine
Gavi signs agreement with Novavax to secure doses on behalf of COVAX
Japan to get 150m doses of Novavax's COVID-19 vaccine candidate